Heather R Sanders

This inventor holds 39 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Cancer Diagnostics. Top assignee: Quest Diagnostics Investments, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Heather R Sanders. Retrieved from https://idiyas.com/inventor/heather-r-sanders

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 39 (Patent Applications = 6)

% Patents Active = 97.4

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 74(Granted Patents)

Location History:

Winchester, CA (US) (2013 - 2024)
RSM, CA (US) (2017 - 2024)
San Juan Capistrano, CA (US) (2018 - 2024)

Company Filing History:

39 out of 499

Quest Diagnostics Investments, Inc.

patents

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Prostate Cancer

EML4-ALK Translocations

Nucleic Acid Detection

RNA Isolation

Tumor Screening

DNA Mutations

Gene Dysregulation

Next-Gen Sequencing

Cystic Fibrosis

Intragenic Expression

Amplification Techniques

Mitra Tip Extraction

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410424 - Diagnosis of prostate cancer (2025-09-09),

2. 12305241 - EML4-ALK translocations in lung cancer (2025-05-20),

3. 12264357 - Universal Sanger sequencing from next-gen sequencing amplicons (2025-04-01),

4. 12018402 - Methods for detecting intracranial neoplasms (2024-06-25),

5. 11981966 - Methods for screening solid tumors for mutations (2024-05-14),

6. 11965212 - Nucleic acid detection combining amplification with fragmentation (2024-04-23),

7. 11965156 - RNA isolation from soluble urine fractions (2024-04-23),

8. 11667909 - Diagnosis of prostate cancer (2023-06-06),

9. 11639529 - EML4-ALK translocations in lung cancer (2023-05-02),

10. 11486005 - Methods for detecting cystic fibrosis mutations using mitra tip extraction (2022-11-01),

11. 11473144 - Methods for detecting cystic fibrosis mutations using mitra tip extraction (2022-10-18),

12. 11441192 - Methods for detecting DNA mutations using mitra tip extraction (2022-09-13),

13. 11441188 - Methods for detecting DNA mutations using Mitra tip extraction (2022-09-13),

14. 11193120 - RNA isolation from soluble urine fractions (2021-12-07),

15. 11155877 - Nucleic acid detection combining amplification with fragmentation (2021-10-26),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can help you with your request. Here is an article about inventor Heather R Sanders:

Title: Heather R Sanders - Pioneering Innovations in Cancer Detection

Introduction:

Heather R Sanders is a prolific inventor known for her groundbreaking work in the field of detecting genetic alterations underlying intracranial neoplasms and solid tumors. With 35 patents to her name, she has significantly advanced the field of personalized medicine.

Latest Patents:

1. Methods for detecting intracranial neoplasms: Heather R Sanders' latest patent focuses on detecting genetic alterations in intracranial neoplasms such as pituitary adenomas, meningiomas, and craniopharyngiomas. These methods help determine the most effective treatment for patients with these tumors.

2. Methods for screening solid tumors for mutations: Another recent patent by Heather R Sanders involves screening solid tumors for mutations in genes related to breast cancer, colorectal cancer, melanoma, and lung cancer. This innovation allows for personalized treatment based on a patient's specific genetic profile.

Career Highlights:

Heather R Sanders currently works at Quest Diagnostics Investments, Inc., a leading company in the field of diagnostic services and personalized medicine. Her contributions have played a crucial role in advancing the company's research and development efforts.

Collaborations:

Heather R Sanders has collaborated with esteemed colleagues such as Maher Albitar and Aurelia Meloni-Ehrig. Together, they have worked on various projects aimed at improving cancer detection and treatment through innovative genetic testing methods.

Conclusion:

Heather R Sanders continues to be a driving force in the field of cancer research, with her innovative patents paving the way for more effective and personalized treatments. Her dedication to improving patient outcomes through cutting-edge technology underscores her commitment to innovation in healthcare.

If you would like more information on inventors, patents, or any other related topics, feel free to ask!

Profile summary based on public USPTO records.